(Q34651442)
Statements
Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma (English)
Gulietta M Pupo
Matteo S Carlino
Robyn Saw
Kavitha Gowrishankar
Stephanie Snoyman
Catherine A B Saunders
1 reference